bpc-157 evidence safety human studies and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Is BPC‑157 a Risk? Safety,

Inactive ingredients: Hydrolyzed chicken flavor, microcrystalline cellulose, silicon dioxide

However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician

Do not take this product if taking the following medications: 5-fluorouracil, ACE inhibitors, activated charcoal, aminoglycoside antibiotics, amiodarone, antacids, anticoagulants/antiplatelet drugs, antidiabetic drugs, antihypertensive drugs, atazanavir, bisphosphonates, blood thinners, calcium channel blockers, capecitabine, cephalexin, chloroquine, cisplatin, digoxin, fosphenytoin, integrase inhibitors, levodopa/carbidopa, methotrexate, nitroglycerin, phenobarbital, penicillamine, phenytoin, potassium-sparing diuretics, primidone, pyrimethamine, quinolone antibiotics, ritonavir, skeletal muscle relaxants, sulfonylureas, and/or tetracycline antibiotics

Moreover, OPLS-DA models were validated by internal iterative cross-validation with seven rounds of permutation test response (800 repeats) not clear, and CV-ANOVA (ANOVA testing of cross-validated predictive residuals)